Quantum Biopharma (QNTM) Return on Capital Employed (2024 - 2026)
Quantum Biopharma (QNTM) reported Return on Capital Employed of 450.31% for Q1 2026, up 68255.0% on a YoY basis from N/an in Q1 2025, and up 294.18% sequentially from 231.9% in Q4 2025.
Quantum Biopharma (QNTM) Return on Capital Employed (2024 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 3 years of Return on Capital Employed data on file, last reported at 450.31% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 68255.0% year-over-year to 450.31%; the trailing twelve-month figure through Mar 2026 stood at 450.31% (up 68255.0% YoY), and the FY2025 full-year result was 189.34%, down 3737.0% from the prior year.
- Return on Capital Employed rose to 450.31% in Q1 2026, from 231.9% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 450.31% in Q1 2026 to a low of 791.35% in Q2 2025.
- A 3-year average of 182.72% and a median of 208.91% in 2025 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed tumbled 12670 bps in 2025 and jumped 68255 bps in 2026, its largest moves.
- Tracing QNTM's Return on Capital Employed over 3 years: stood at 105.2% in 2024, then slumped by 120 bps to 231.9% in 2025, then soared by 294 bps to 450.31% in 2026.
- Business Quant data shows QNTM's Return on Capital Employed at 450.31% in Q1 2026, 231.9% in Q4 2025, and 185.93% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Quantum Biopharma | 2.61 Bn | 2.60 Bn | - | 450.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 450.31% |
| Dec 31, 2025 | -231.90% |
| Sep 30, 2025 | -185.93% |
| Jun 30, 2025 | -791.35% |
| Mar 31, 2025 | -232.25% |
| Dec 31, 2024 | -105.20% |